Prolongation of the QTc interval in African children treated for falciparum malaria.

Prolongation of the QTc interval in African children treated for falciparum malaria.

Afficher d'autres versions (1)

Détails bibliographiques
Auteurs principaux:	Price, R, Nosten, F, White, N
Format:	Journal article
Langue:	English
Publié:	1998

Documents similaires

Prolongation of the QTc interval in African children treated for falciparum malaria
par: Price, R, et autres
Publié: (1998)

QTc Prolongation and Ventricular Trigemini with Asenapine: A Case Report
par: Gill, Jesjeet Singh, et autres
Publié: (2017)

Letter by Herring and Paterson regarding article, "Common NOS1AP variants are associated with a prolonged QTc interval in the Rotterdam Study".
par: Herring, N, et autres
Publié: (2007)

Combining an in silico proarrhythmic risk assay with a tPKPD model to predict QTc interval prolongation in the anesthetized guinea pig assay
par: Morissette, P, et autres
Publié: (2020)

Effect of Age and Sex on the QTc Interval in Children and Adolescents With Type 1 and 2 Long-QT Syndrome
par: Vink, A, et autres
Publié: (2017)

Pathophysiology of fatal falciparum malaria in African children.
par: Newton, C, et autres
Publié: (1998)

Neurological features of falciparum malaria in African children
par: Idro, R, et autres
Publié: (2006)

Management of severe falciparum malaria in African children.
par: Newton, C
Publié: (2004)

Does artesunate prolong the electrocardiograph QT interval in patients with severe malaria?
par: Maude, R, et autres
Publié: (2009)

Parenteral chloroquine for treating falciparum malaria.
par: White, N, et autres
Publié: (1987)

Adverse effects in patients with acute falciparum malaria treated with artemisinin derivatives.
par: Price, R, et autres
Publié: (1999)

Absorption of intramuscular phenobarbitone in children with severe falciparum malaria.
par: Kuile, F, et autres
Publié: (1992)

MEFLOQUINE PHARMACOKINETICS AND RESISTANCE IN CHILDREN WITH ACUTE FALCIPARUM-MALARIA
par: Nosten, E, et autres
Publié: (1991)

DISPERSI QTc (QTcD) SEBAGAI UJI SARING MORBIDITAS JANTUNG PADA PENDERITA THALASSEMIA ANAK-ANAK
par: , Intan Patah Kumara, et autres
Publié: (2012)

Pharmacokinetics of mefloquine combined with artesunate in children with acute falciparum malaria.
par: Price, R, et autres
Publié: (1999)

The genetic risk of acute seizures in African children with falciparum malaria.
par: Kariuki, S, et autres
Publié: (2013)

Symptomatic illness and treatment of Plasmodium falciparum malaria in African children
par: Dalrymple, U
Publié: (2018)

Mefloquine pharmacokinetics and resistance in children with acute falciparum malaria.
par: Nosten, F, et autres
Publié: (1991)

Artemisinin-based combination treatment of falciparum malaria.
par: Nosten, F, et autres
Publié: (2007)

Efficacy and day 7 plasma piperaquine concentrations in African children treated for uncomplicated malaria with dihydroartemisinin-piperaquine
par: Zongo, I, et autres
Publié: (2014)

Persistence of Plasmodium falciparum HRP-2 in successfully treated acute falciparum malaria.
par: Mayxay, M, et autres
Publié: (2001)

Hypoglycaemia in African children with severe malaria.
par: White, N, et autres
Publié: (1987)

WILL REDUCING PLASMODIUM-FALCIPARUM TRANSMISSION ALTER MALARIA MORTALITY AMONG AFRICAN CHILDREN
par: Snow, R, et autres
Publié: (1995)

Falciparum malaria in pregnancy.
par: Mcgready, R, et autres
Publié: (1995)

The influence of alanine infusion on glucose production in 'malnourished' African children with falciparum malaria.
par: Dekker, E, et autres
Publié: (1997)

Drugs that reduce transmission of falciparum malaria.
par: Price, R, et autres
Publié: (2018)

Artemisinin Resistance in Plasmodium falciparum Malaria REPLY
par: Dondorp, A, et autres
Publié: (2009)

Quantifying the contribution of Plasmodium falciparum malaria to febrile illness amongst African children
par: Dalrymple, U, et autres
Publié: (2017)

Quantifying the contribution of Plasmodium falciparum malaria to febrile illness amongst African children
par: Dalrymple, U, et autres
Publié: (2017)

Drug resistant falciparum malaria: clinical consequences and strategies for prevention.
par: Price, R, et autres
Publié: (2001)

Population pharmacokinetics and pharmacodynamics of piperaquine in children with uncomplicated falciparum malaria.
par: Tarning, J, et autres
Publié: (2012)

Population pharmacokinetics and pharmacodynamics of piperaquine in children with uncomplicated falciparum malaria
par: Tarning, J, et autres
Publié: (2012)

Cost of treating inpatient falciparum malaria on the Thai-Myanmar border
par: Kyaw, S, et autres
Publié: (2014)

Glucose metabolism in quinine-treated patients with uncomplicated falciparum malaria.
par: Davis, T, et autres
Publié: (1990)

Artesunate for severe malaria in African children Reply
par: Dondorp, A, et autres
Publié: (2011)

Overview of non-falciparum malaria in nonpregnant adults and children
par: Baird, J, et autres
Publié: (2016)

Factors affecting haemoglobin dynamics in African children with acute uncomplicated Plasmodium falciparum malaria treated with single low-dose primaquine or placebo
par: Onyamboko, MA, et autres
Publié: (2023)

Post-treatment haemolysis in African children with hyperparasitaemic falciparum malaria; a randomized comparison of artesunate and quinine
par: Fanello, C, et autres
Publié: (2017)

A case-control auditory evaluation of patients treated with artemisinin derivatives for multidrug-resistant Plasmodium falciparum malaria.
par: Van Vugt, M, et autres
Publié: (2000)

Conflicting immune responses can prolong the length of infection in Plasmodium falciparum malaria.
par: Recker, M, et autres
Publié: (2006)